Kite Pharma, Inc.

Historical 13F Holders

Symbol
KITE
CUSIP
49803L109
All holders as of
Q3 2017
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2017 Q3 302 49.4 M $8.88 B
2017 Q2 256 50.7 M $5.24 B
2017 Q1 241 48.7 M $3.82 B
2016 Q4 211 44.9 M $2.01 B
2016 Q3 233 38.7 M $2.16 B
2016 Q2 187 37.7 M $1.89 B
2016 Q1 187 37.0 M $1.70 B
2015 Q4 206 36.9 M $2.28 B
2015 Q3 176 33.6 M $1.87 B
2015 Q2 172 30.2 M $1.84 B
2015 Q1 165 25.8 M $1.49 B
2014 Q4 122 20.9 M $1.21 B
2014 Q3 63 9.67 M $273 M
2014 Q2 5 241 k $6.98 M